Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 2/20 | 0.78 |
| ▸ | PLK1 | P53350 | 1/20 | 0.67 |
| ▸ | HPGDS | O60760 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | HPGD | P15428 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | STAT6 | P42226 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11445757 | 0.98 | CDC25B (0.76) | CDC25BPLK1HPGDSCYP2C9HIF1A | |
| Cyanide SCHEMBL11198616 | 0.95 | CDC25B (0.71) | CDC25BPLK1HPGDSCYP2C9HIF1A | |
| SCHEMBL7560388 | 0.95 | CDC25B (0.88) | CDC25BPLK1HPGDSCYP2C9HIF1A | |
| SCHEMBL4103770 | 0.89 | CDC25B (0.68) | CDC25BPLK1HPGDSCYP2C9HIF1A | |
| SCHEMBL28066258 | 0.88 | HTT (0.68) | CDC25BPLK1HPGDSCYP2C9HIF1A | |
| SCHEMBL14124732 | 0.88 | CDC25B (1.00) | CDC25BPLK1HPGDSCYP2C9HIF1A | |
| SCHEMBL14124722 | 0.85 | CDC25B (0.64) | CDC25BPLK1HPGDSCYP2C9HIF1A | |
| SCHEMBL4518755 | 0.85 | PLK1 (0.67) | CDC25BPLK1HPGDSCYP2C9HIF1A | |
| SCHEMBL7842295 | 0.85 | PLK1 (0.67) | CDC25BPLK1HPGDSCYP2C9HIF1A | |
| SCHEMBL10420596 | 0.84 | CDC25B (0.57) | CDC25BPLK1HPGDSCYP2C9HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | claimed |
| CN-111440137-B | 3, 4-benzocoumarin derivative and preparation method and application thereof | 华东理工大学 | 2022-08-16 | — | — | CN | claimed |
| CN-109836618-B | Modification method of aluminum oxide | 中国石油天然气股份有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-111440137-A | 3, 4-benzocoumarin derivative and preparation method and application thereof | 华东理工大学 | 2020-07-24 | — | — | CN | claimed |
| CN-111410603-A | Benzanthrone derivative, preparation method thereof and application thereof in functional pigment | 上海甘田光学材料有限公司 | 2020-07-14 | — | — | CN | claimed |
| CN-117658749-B | Method for preparing aryl carboxylic acid by reacting copper compound catalyzed aryl sulfonium salt with carbon dioxide | NANKAI UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-119822986-A | Amide compound and synthesis method thereof | 海南大学 | 2025-04-15 | — | — | CN | disclosed |
| CN-113801087-B | Benzo-six-membered ring derivatives as DPP-4 inhibitors and uses thereof | 山东百极地长制药有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-113801088-B | Benzo six-membered ring derivative and application thereof | 山东百极地长制药有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117658749-A | Method for preparing aryl carboxylic acid by reacting copper compound catalyzed aryl sulfonium salt with carbon dioxide | 南开大学 | 2024-03-08 | — | — | CN | disclosed |
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | disclosed |
| CN-111410603-B | Benzanthrone derivative, preparation method thereof and application thereof in functional pigment | 上海甘田光学材料有限公司 | 2022-12-16 | — | — | CN | disclosed |
| US-6960607-B2 | Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents | WYETH (US) | 2005-11-01 | — | — | US | disclosed |
| EP-1546086-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-06-29 | — | — | EP | disclosed |
| US-20040127574-A1 | Aminoethanol derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-07-01 | — | — | US | disclosed |
| US-20040006143-A1 | For therapy of urinary incontinence | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-01-08 | — | — | US | disclosed |
| WO-2004002939-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-01-08 | — | — | WO | disclosed |
| EP-1362846-A1 | AMINOETHANOL DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 2003-11-19 | — | — | EP | disclosed |
| US-20030171412-A1 | Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents | WYETH | 2003-09-11 | — | — | US | disclosed |
| US-5162203-A | Aromatic aldehyde substrates | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1992-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127574-A1 | Aminoethanol derivatives | CETP, LCAT, MTTP | CDC25B 4813/4885PLK1 4054/4885HPGDS 2098/4885 |
| US-20030171412-A1 | Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents | ESR1, ESR2, ESRRA | CDC25B 2238/4885PLK1 2697/4885HPGDS 2907/4885 |
| US-20040006143-A1 | For therapy of urinary incontinence | H1-0, HRH2, H1-2 | CDC25B 2961/4885PLK1 3722/4885HPGDS 2838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.